HC Pharma
ActiveFrom the official registers: KBO 47 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of HC Pharma is 3.2% (moderate). The 2025 annual accounts show negative equity (-€992,548) and a net result of -€235,534. Equity is growing by about 4.7% per year across the filed financial years. Its solvency ranks better than 9% of 12,737 sector peers (NACE 47, financial year 2025). The company has been active since 1961 and the Belgian Official Gazette contains no insolvency or warning signals.